Voyager Therapeutics (VYGR) traded down -6.45 % during a 24 hours period ending at 06:20 PM Central Europe on Monday 26th. One Voyager Therapeutics stock can currently be bought for about USD 1.72 on popular exchanges. Current supply of Voyager Therapeutics stocks is 61.6 mn. Voyager Therapeutics has a current market capitalization of USD 107.2 mn and approximately USD 1.8 mn worth of Voyager Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Voyager Therapeutics has traded -37.86 % down. Simple moving average of last 200 days is at USD 3.52. The highest price of past 52 weeks was recorded at USD 5.48 on 03/11/2026. 52 weeks low was at USD 1.74 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Magyar (MGYR) traded up 3.54 % and now trades at USD 19.8. Current market capitalisation for Magyar is USD 128.5 mn. Current price/earnings ratio for Magyar is 10.37.
Cumberland (CPIX) traded up 0.12 % and now trades at USD 5.16. Cumberland has a market capitalisation of USD 127.2 mn.
Health Catalyst (HCAT) traded down -2.87 % and now trades at USD 1.65. Health Catalyst has a market capitalisation of USD 127.2 mn.
Organogenesis (ORGO) traded down -3.59 % and now trades at USD 0.97. Current market capitalisation for Organogenesis is USD 127.8 mn.
Nkarta (NKTX) traded up 2.87 % and now trades at USD 1.81. Current market capitalisation for Nkarta is USD 128.2 mn.
About Voyager Therapeutics
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company based in Cambridge, Massachusetts, USA. The company specializes in developing life-changing treatments for patients suffering from severe diseases of the central nervous system. Voyager Therapeutics Inc. focuses on creating gene therapies for fatal and debilitating conditions. You can find more information about their activities and offerings on their website, which is www.voyagertherapeutics.com . They are listed on the Nasdaq stock exchange and their IPO date is November 11, 2015.
